Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study

This study aimed to compare adalimumab originator vs. biosimilar in HS patients, and to evaluate the effect of a switch to a biosimilar, or a switch back to the originator, in terms of treatment ineffectiveness. Patients with a diagnosis of HS were enrolled from 14 Italian sites. Treatment ineffecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Burlando, Martina, Fabbrocini, Gabriella, Marasca, Claudio, Dapavo, Paolo, Chiricozzi, Andrea, Malvaso, Dalma, Dini, Valentina, Campanati, Anna, Offidani, Annamaria, Dattola, Annunziata, Caro, Raffaele Dante Caposiena, Bianchi, Luca, Venturini, Marina, Gisondi, Paolo, Guarneri, Claudio, Malara, Giovanna, Trifirò, Caterina, Malagoli, Piergiorigio, Fargnoli, Maria Concetta, Piaserico, Stefano, Carmisciano, Luca, Castelli, Riccardo, Parodi, Aurora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599334/
https://www.ncbi.nlm.nih.gov/pubmed/36289787
http://dx.doi.org/10.3390/biomedicines10102522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599334/
https://www.ncbi.nlm.nih.gov/pubmed/36289787
http://dx.doi.org/10.3390/biomedicines10102522

Ejemplares similares